Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility

Jacob K. Kettle, PharmD, BCOP
Oncology Clinical Pharmacy Specialist,
Department of Pharmacy,
University of Missouri Health Care,
Columbia, MO
Jacob K Kettle, PharmD, BCOP, Oncology Clinical Pharmacy Specialist, Department of Pharmacy, University of Missouri Health Care, Columbia, MO, discusses the clinical significance of his study, “Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility.”
Related Items
Comparing Granulocyte Colony-Stimulating Factors Prescribing Practices versus Guideline Recommendations in a Large Community Cancer Center
Kirollos S. Hanna, PharmD, BCPS, BCOP, Robert Mancini, PharmD, BCOP, Dave Wilson, PharmD, Dan Zuckerman, MD
JHOP - September 2019 Vol 9, No 3 published on September 9, 2019 in Practical Issues for Pharmacists
Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib
Justin Arnall, PharmD, BCOP, CPP
Audiocasts published on July 1, 2016 in Original Research, Audiocast
Management of Hypercalcemia of Malignancy
Sonia Amin Thomas (Sonia Patel), PharmD
Audiocasts published on May 25, 2016 in Supportive Care, Audiocast
ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders
Web Exclusives published on February 23, 2016 in Practical Issues for Pharmacists
Evaluating the Effects of a 14-Day Oral Chemotherapy Dispensing Protocol on Adherence, Toxicity, and Cost
Shardae Young, PharmD, BCPS
Audiocasts published on October 5, 2015 in Original Research, Audiocast
Implementation of and Satisfaction with an Outpatient Oral Anticancer Therapy Program
Emily R Mackler, PharmD, BCOP
Audiocasts published on September 9, 2015 in Original Research, Audiocast
Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility
Elizabeth Gustafson, PharmD, Jacob K. Kettle, PharmD, BCOP
JHOP - June 2015 Vol 5, No 2 published on June 2, 2015 in Original Research
Raising Awareness on the Use of LMWH in Patients with Acute Venous Thromboembolism and Active Cancer
David W Stewart, PharmD, BCPS
Audiocasts published on April 15, 2015 in Practical Issues for Pharmacists, Audiocast
The Impact of Angiotensin II Receptor Blocker Use in Patients with Prostate Cancer
Lisa Cerutti, PharmD, Jacob K. Kettle, PharmD, BCOP, Dennis Grauer, PhD
JHOP - December 2013 VOL 3, NO 4 published on December 20, 2013 in Original Research
Financial Savings from On-Site Dispensing of Oral Chemotherapies
Adam Kramer, PharmD, Colleen Powell, CPhT
JHOP - September 2013 VOL 3, NO 3 published on September 13, 2013 in Practical Issues for Pharmacists
Last modified: April 27, 2020